The future therapy of endometrial cancer: microRNA’s functionality, capability, and putative clinical application

Purpose Endometrial cancer (EC) therapy is characterized by the heterogeneity of EC subtypes resulting in unclear clinical behavior as well as in unsatisfactory treatment options. The available biomarkers, such as cellular tumor antigen p53 (TP53), phosphatidylinositol 3,4,5-trisphosphate 3-phosphat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of gynecology and obstetrics 2016-11, Vol.294 (5), p.889-895
Hauptverfasser:	Stope, Matthias B., Koensgen, Dominique, Weimer, Jörg, Paditz, Madeleine, Burchardt, Martin, Bauerschlag, Dirk, Mustea, Alexander
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Cell cycle Endocrinology Endometrial cancer Endometrial Neoplasms - genetics Endometrial Neoplasms - metabolism Endometrial Neoplasms - pathology Endometrial Neoplasms - therapy Female Gynecology Human Genetics Humans Kinases Medicine Medicine & Public Health MicroRNAs MicroRNAs - genetics MicroRNAs - metabolism Obstetrics/Perinatology/Midwifery Phosphatase Prognosis Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!